アルブミン添加剤の世界市場レポート 2025年

アルブミン添加剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で67億7,000万米ドルに成長します。予測期間の成長は、バイオ医薬品の継続的な拡大、生物製剤パイプラインの増加、高齢者人口の増加、世界のワクチン接種の取り組み、医薬品開発投資の増加などに起因すると考えられます。予測期間における主な動向としては、生分解性・生体適合性、研究における共同研究・提携、規制遵守・品質基準、細胞治療への応用、カスタマイズ・ソリューションなどが挙げられます。

慢性疾患の有病率の増加が、今後のアルブミン添加剤市場の成長を牽引すると予想されます。慢性疾患とは、3ヵ月以上持続し、時間の経過とともに悪化する病気のことです。血漿中に最も豊富に存在する循環タンパク質であるアルブミンは、血液容積増加剤および多目的タンパク質キャリアとして機能し、薬剤の標的化を助け、がんや糖尿病を含む様々な疾患の治療に使用されるペプチドまたはタンパク質ベースの薬剤の薬物動態プロファイルを向上させる。例えば、2024年2月、スイスに本部を置く国連機関である世界保健機関（WHO）は、2050年までに3,500万人以上のがん患者が新たに発生し、2022年の推定2,000万人から77％増加すると予測しています。このように、慢性疾患の有病率の上昇は、アルブミン添加剤市場の成長を促進する重要な要因です。

ヘルスケア支出の増加は、今後のアルブミン添加剤市場の成長を促進すると予想されます。医療費には、保健サービスの提供、家族計画イニシアチブ、栄養プログラム、緊急保健支援に関連するすべての費用が含まれます。医療支出の増加は、医薬品やバイオ医薬品における高度なアルブミンベースの製剤の開発や使用に財政的支援を提供することで、アルブミン添加剤市場にプラスの影響を与えます。例えば、カナダに本部を置く非営利団体Canadian Institute for Health Informationは、2023年11月に、2023年の総医療費は3,440億米ドルに達すると予測され、前年比2.8%の緩やかな成長を示すと報告しています。したがって、ヘルスケア支出の増加は、アルブミン添加剤市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アルブミン添加剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のアルブミン添加剤市場：成長率分析
• 世界のアルブミン添加剤市場の実績：規模と成長, 2019-2024
• 世界のアルブミン添加剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界アルブミン添加剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアルブミン添加剤市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト血清アルブミン
• 組み換えアルブミン
• 世界のアルブミン添加剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー業界
• 調査機関
• その他のエンドユーザー
• 世界のアルブミン添加剤市場、ヒト血清アルブミンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 5%ヒト血清アルブミン
• 20%ヒト血清アルブミン
• 世界のアルブミン添加剤市場、組換えアルブミンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えヒト血清アルブミン
• 組換えウシ血清アルブミン

第7章 地域別・国別分析

• 世界のアルブミン添加剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアルブミン添加剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アルブミン添加剤市場：競合情勢
• アルブミン添加剤市場：企業プロファイル
  • Albumin Therapeutics LLC Overview, Products and Services, Strategy and Financial Analysis
  • Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • CSL Behring Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • HiMedia Laboratories LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• InVitria Inc.
• Medxbio Pte Ltd.
• Octapharma AG
• RayBiotech Inc.
• SeraCare Life Sciences Inc.
• Sigma-Aldrich Pty. Ltd.
• Hualan Biological Engineering Inc.
• Kedrion Biopharma
• LFB USA Inc.
• Shanghai RAAS Blood Products Co. Ltd.
• Baxter International Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Albumedix A/S
• Bio Products Laboratory Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アルブミン添加剤市場2029：新たな機会を提供する国
• アルブミン添加剤市場2029：新たな機会を提供するセグメント
• アルブミン添加剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Albumin excipient refers to a protein derived from blood, serving as an inactive ingredient in pharmaceutical formulations. As an excipient, it functions as a carrier or stabilizer for the active pharmaceutical ingredient.

The primary product types of albumin excipients include human serum albumin and recombinant albumin. Human serum albumin, the principal protein synthesized by the liver and found in human plasma, is a key component. These albumin excipients find applications across various end-users, including the pharmaceutical and biotechnology industry, research institutes, and other related fields.

The albumin excipient market research report is one of a series of new reports from The Business Research Company that provides albumin excipient market statistics, including albumin excipient industry global market size, regional shares, competitors with an albumin excipient market share, detailed albumin excipient market segments, market trends and opportunities, and any further data you may need to thrive in the albumin excipient industry. This albumin excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The albumin excipient market size has grown strongly in recent years. It will grow from$4.85 billion in 2024 to $5.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to biopharmaceutical industry growth, increased adoption of biologics, risen prevalence of chronic diseases, clinical advancements and drug innovation, increased focus on drug delivery

The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to continued biopharmaceutical expansion, growing biologics pipeline, rising geriatric population, global vaccination initiatives, increasing drug development investments. Major trends in the forecast period include biodegradable and biocompatible properties, collaborations and partnerships in research, regulatory compliance and quality standards, application in cell therapy, customization and tailored solutions.

The increasing prevalence of chronic diseases is expected to drive the growth of the albumin excipient market in the future. Chronic diseases are illnesses that persist for three months or longer and can worsen over time. Albumin, the most abundant circulating protein in plasma, serves as a blood volumizer and a versatile protein carrier, aiding in drug targeting and enhancing the pharmacokinetic profile of peptide or protein-based medications used to treat various conditions, including cancer and diabetes. For instance, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that more than 35 million new cancer cases will occur by 2050, representing a 77% increase from an estimated 20 million cases in 2022. Thus, the rising prevalence of chronic diseases is a significant factor propelling the growth of the albumin excipient market.

The increase in healthcare expenditures is expected to drive the growth of the albumin excipient market in the future. Health expenditures encompass all costs related to delivering health services, family planning initiatives, nutrition programs, and emergency health assistance. Rising healthcare spending positively impacts the albumin excipient market by providing increased financial support for the development and use of advanced albumin-based formulations in pharmaceuticals and biopharmaceuticals. For example, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is projected to reach $344 billion in 2023, indicating a modest growth of 2.8% compared to the previous year. Therefore, the rise in healthcare expenditures is a significant factor driving the growth of the albumin excipient market.

Leading companies in the albumin excipient market are increasingly adopting a strategic partnership approach to support the biotechnology and pharmaceutical sectors. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in October 2023, ARTES Biotechnology GmbH, a Germany-based biotechnology firm, partnered with Basic Pharma, a pharmaceutical company based in the Netherlands, to enhance recombinant protein production. Through this collaboration, they aim to optimize the supply chain and reduce the time-to-market for new products in the pharmaceutical sector.

Major companies in the albumin excipient market are also engaging in collaborations to foster new relationships and jointly develop innovative medicines. In June 2023, Albumedix Ltd., a UK-based pharmaceutical company, expanded its collaboration with Valneva SE to include Valneva's newly approved inactivated COVID-19 vaccine, VLA2001. This collaboration aims to address significant unmet medical needs, with Albumedix's rHA making a substantial contribution to the vaccine's manufacturing process. Valneva SE, a France-based biotech company, specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases, including VLA2001, the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe.

In September 2022, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment manufacturer, made a strategic acquisition by purchasing Albumedix for $503 million. This acquisition strengthens Sartorius Inc.'s cell culture media business by expanding its portfolio of bioprocess solutions. This strategic move enhances Sartorius Inc.'s capabilities and market presence in the rapidly evolving field of bioprocessing. Albumedix, a UK-based company, focuses on the development and manufacturing of recombinant human albumin products, contributing to the advancement of biopharmaceuticals.

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

North America was the largest region in the Albumin Excipient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the albumin excipient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The albumin excipient market consists of sales of ovalbumin, and bovine serum albumin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Albumin Excipient Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albumin excipient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for albumin excipient ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The albumin excipient market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Human Serum Albumin; Recombinant Albumin
• 2) By End-Users: Pharmaceutical And Biotechnology Industry; Research Institutes; Other End Users
• Subsegments:
• 1) By Human Serum Albumin: 5% Human Serum Albumin; 20% Human Serum Albumin
• 2) By Recombinant Albumin: Recombinant Human Serum Albumin; Recombinant Bovine Serum Albumin
• Companies Mentioned: Albumin Therapeutics LLC; Biotest AG; CSL Behring;Grifols S.A.; HiMedia Laboratories LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Albumin Excipient Market Characteristics

3. Albumin Excipient Market Trends And Strategies

4. Albumin Excipient Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Albumin Excipient Growth Analysis And Strategic Analysis Framework

• 5.1. Global Albumin Excipient PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Albumin Excipient Market Growth Rate Analysis
• 5.4. Global Albumin Excipient Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Albumin Excipient Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Albumin Excipient Total Addressable Market (TAM)

6. Albumin Excipient Market Segmentation

• 6.1. Global Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Serum Albumin
• Recombinant Albumin
• 6.2. Global Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Industry
• Research Institutes
• Other End Users
• 6.3. Global Albumin Excipient Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5% Human Serum Albumin
• 20% Human Serum Albumin
• 6.4. Global Albumin Excipient Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Human Serum Albumin
• Recombinant Bovine Serum Albumin

7. Albumin Excipient Market Regional And Country Analysis

• 7.1. Global Albumin Excipient Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Albumin Excipient Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Albumin Excipient Market

• 8.1. Asia-Pacific Albumin Excipient Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Albumin Excipient Market

• 9.1. China Albumin Excipient Market Overview
• 9.2. China Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Albumin Excipient Market

• 10.1. India Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Albumin Excipient Market

• 11.1. Japan Albumin Excipient Market Overview
• 11.2. Japan Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Albumin Excipient Market

• 12.1. Australia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Albumin Excipient Market

• 13.1. Indonesia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Albumin Excipient Market

• 14.1. South Korea Albumin Excipient Market Overview
• 14.2. South Korea Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Albumin Excipient Market

• 15.1. Western Europe Albumin Excipient Market Overview
• 15.2. Western Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Albumin Excipient Market

• 16.1. UK Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Albumin Excipient Market

• 17.1. Germany Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Albumin Excipient Market

• 18.1. France Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Albumin Excipient Market

• 19.1. Italy Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Albumin Excipient Market

• 20.1. Spain Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Albumin Excipient Market

• 21.1. Eastern Europe Albumin Excipient Market Overview
• 21.2. Eastern Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Albumin Excipient Market

• 22.1. Russia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Albumin Excipient Market

• 23.1. North America Albumin Excipient Market Overview
• 23.2. North America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Albumin Excipient Market

• 24.1. USA Albumin Excipient Market Overview
• 24.2. USA Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Albumin Excipient Market

• 25.1. Canada Albumin Excipient Market Overview
• 25.2. Canada Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Albumin Excipient Market

• 26.1. South America Albumin Excipient Market Overview
• 26.2. South America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Albumin Excipient Market

• 27.1. Brazil Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Albumin Excipient Market

• 28.1. Middle East Albumin Excipient Market Overview
• 28.2. Middle East Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Albumin Excipient Market

• 29.1. Africa Albumin Excipient Market Overview
• 29.2. Africa Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Albumin Excipient Market Competitive Landscape And Company Profiles

• 30.1. Albumin Excipient Market Competitive Landscape
• 30.2. Albumin Excipient Market Company Profiles
  • 30.2.1. Albumin Therapeutics LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. CSL Behring Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. HiMedia Laboratories LLC Overview, Products and Services, Strategy and Financial Analysis

31. Albumin Excipient Market Other Major And Innovative Companies

• 31.1. InVitria Inc.
• 31.2. Medxbio Pte Ltd.
• 31.3. Octapharma AG
• 31.4. RayBiotech Inc.
• 31.5. SeraCare Life Sciences Inc.
• 31.6. Sigma-Aldrich Pty. Ltd.
• 31.7. Hualan Biological Engineering Inc.
• 31.8. Kedrion Biopharma
• 31.9. LFB USA Inc.
• 31.10. Shanghai RAAS Blood Products Co. Ltd.
• 31.11. Baxter International Inc.
• 31.12. Merck KGaA
• 31.13. Thermo Fisher Scientific Inc.
• 31.14. Albumedix A/S
• 31.15. Bio Products Laboratory Ltd.

32. Global Albumin Excipient Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Albumin Excipient Market

34. Recent Developments In The Albumin Excipient Market

35. Albumin Excipient Market High Potential Countries, Segments and Strategies

• 35.1 Albumin Excipient Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Albumin Excipient Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Albumin Excipient Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer